Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

Longevity Economy strategy - July 2021

  • 12 August 2021 (7 min read)

Start of earnings season shows a rebound in demand for medical treatment depressed during the pandemic

  • Global markets continued to rally, establishing fresh all-time highs
  • Positive performance from all our four themes, led by “senior care” and “wellness”
  • Focus remains on long-term changes brought about by ageing populations

What’s happening?

Many companies started reporting second quarter financial results in July. One of the key trends in results reported so far is returning demand for medical treatment that was depressed during the height of the pandemic in developed markets. Companies exposed to surgical procedures and emergency room visits reported rebounding demand close to or, in some cases, in excess of pre-pandemic volumes. Generally, physicians are seeing patients with more serious conditions than normal, most likely due to patients not seeking treatment due to the pandemic.

Interestingly, many consumer products that saw robust demand during the pandemic last year, such as fitness apparel and recreational boat manufacturers, continue to report strong results indicating more durable changes in consumer demand than many expected.

Financial planning, wealth management and asset management services have also enjoyed a prosperous start to the year as stock markets reached fresh all-time highs during July. There is an ongoing debate about the future direction of inflation, many company executives noted some increases in input costs, but most indicated they expected increases to be manageable and, to some extent, transitory. Which may explain why financial markets continue to perform positively despite signs of increasing inflation.

Portfolio positioning and performance

The Longevity Economy strategy outperformed the broader market equities (MSCI All Country World) in July with positive performance from all four of the strategy’s themes: Wellness, Silver spending, Senior care and Treatment.

Focusing on the care needs of senior citizens is a core theme of the longevity economy. Ageing populations are expected to drive significant growth in demand for senior care services. Companies such as HCA Healthcare and Service Corporation International are well-placed to benefit from a demand increase include hospital operators, home health providers and funeral services. Funeral services are benefitting from an increasing trend towards prefunding of funeral services, in which consumers plan for their final send off during their life rather than leaving it to their surviving relatives. Furthermore, over the short term, there is a rebound in revenues for funeral care providers occurring as social distancing requirements are eased and larger services with more attendees can be organised again.

The wellness theme of ageing acknowledges that we must live healthier throughout our lives if we want to reach our later years in good health. Lifelong fitness is a key aspect of this and in July we saw strong share price performance from gym operators, fitness apparel and equipment providers such as Basic-Fit. In contrast, telehealth providers continued to see more volatility as investors attempt to discern the sustainable rate of growth after the surge in demand driven by the pandemic subsides. Similarly, the shares of European MedTech company, Philips struggled after issuing a product recall for some of its respiratory devices.


Global markets continued to rally in July, setting fresh all-time highs driven by positive economic growth in multiple regions. However, at times economic data has been contradictory, for example the US Federal Reserve recently moved forward its expected timing for interest rate increases and inflation appears to be rising in multiple regions, which could present further problems for policymakers. Overall, we remain cautiously optimistic because data from the UK’s recent surge coronavirus cases has shown lower hospitalisation rates that demonstrate the benefit and safety of the COVID-19 vaccines. However, caution is warranted over the recent increase in COVID-19 cases in the Southern United States due to the lower rate of vaccination in many of these states. Already some social distancing and mask-wearing requirements are being reimposed, the impact of these measures on regional economies is not clear, but could unsettle markets.

Stepping back from macroeconomic considerations, we retain the view that high quality management teams, operating businesses with a sustainable competitive advantage and with the benefit of secular tailwinds are well-placed to navigate the current disruption. Despite the headwinds many businesses faced during the pandemic, the unshakeable conclusion on the outlook for the longevity economy is that the global population continues to age and this creates opportunities for companies that are positioned to benefit from long-term changes in consumption patterns that ageing populations will bring.

No assurance can be given that the Longevity Economy Strategy will be successful. Investors can lose some or all of their capital invested. The Longevity Economy Strategy is subject to risks including: Equity; Currency; Global Investments; Emerging markets; Investments in small capitalisation universe and Investment in specific asset classes.

Read the full article
Download article (224.19 KB)

Related Articles


Global Thematics strategy - February 2023

  • by David Shaw, Mark Hargraves
  • 21 February 2023 (5 min read)

Global Thematics strategy - January 2023

  • by David Shaw, Mark Hargraves
  • 15 February 2023 (5 min read)

Global Thematics strategy - July 2022

  • by Amanda O’Toole
  • 19 August 2022 (5 min read)

    Not for Retail distribution

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check the countries of registration with the asset manager, or on the web site https://www.axa-im.com/en/registration-map, where a fund registration map is available. Please note that the management company reserves the right, at any time, to no longer market the product(s) mentioned in this communication in an European Union country by notification to its authority of supervision in accordance with European passport rules. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisors.

    In the event of dissatisfaction with the products or services, you have the right to make a complaint either with the marketer or directly with the management company (more information on our complaints policy available in English here). You also have the right to take legal or extra-judicial action at any time if you reside in one of the countries of the European Union. The European online dispute resolution platform allows you to enter a complaint form (by clicking here) and informs you, depending on your jurisdiction, about your means of redress (by clicking here).

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. 

    Are you an IFA or other Professional Investor ?

    Are you a financial advisor, institutional, or other professional investor?

    This section is for professional investors only. You need to confirm that you have the required investment knowledge and experience to view this content. This includes understanding the risks associated with investment products, and any other required qualifications according to the rules of your jurisdiction.